eFFECTOR Therapeutics
Thomas Kevin Gregorczyk has a extensive background in pharmaceutical development operations, with experience in roles such as Senior Director, Associate Director, and Manager. Thomas Kevin has worked at companies like eFFECTOR Therapeutics, Halozyme Therapeutics, and Avanir Pharmaceuticals. Thomas has also held positions at Sherpa Clinical Packaging, Bilcare Limited, Amylin Pharmaceuticals, Ligand Pharmaceuticals, and Knoll Pharmaceuticals. Their responsibilities have included overseeing packaging and labeling staff, managing clinical trial materials, and coordinating investigational supplies. Thomas has received education from Community College and Haughton High School.
This person is not in any teams
This person is not in any offices
eFFECTOR Therapeutics
eFFECTOR Therapeutics is a clinical-stage biopharmaceutical company focused on pioneering the discovery and development of a new class of oncology drugs known as selective translation regulators (STRs).